Table 1 Patient characteristics at baseline
From: Chronic kidney disease in gout in a managed care setting
Patient characteristics | No CKD (n) | No CKD (%) | Stage 2 CKD (n) | Stage 2 CKD (%) | Stage 3 CKD (n) | Stage 3 CKD (%) | Stage 4 CKD (n) | Stage 4 CKD (%) | p-value* |
|---|---|---|---|---|---|---|---|---|---|
All patients | 2,393 | - | 1,032 | - | 357 | - | 147 | - | |
Age group (years) | |||||||||
≤44 | 858 | 35.85 | 138 | 13.37 | 38 | 10.64 | 33 | 22.45 | < .0001 |
45-64 | 1,503 | 62.81 | 812 | 78.68 | 264 | 73.95 | 104 | 70.75 | |
65-74 | 31 | 1.3 | 79 | 7.66 | 48 | 13.45 | 9 | 6.12 | |
75+ | 1 | 0.04 | 3 | 0.29 | 7 | 1.96 | 1 | 0.68 | |
Male gender | 2,121 | 88.63 | 896 | 86.82 | 300 | 84.03 | 120 | 81.63 | 0.0082 |
mean | SD | mean | SD | mean | SD | mean | SD | ||
Number of comorbidities | 6.85 | 4.81 | 7.51 | 5.33 | 9.68 | 5.83 | 8.19 | 5.53 | < .0001 |
Charlson-Deyo Comorbidity Index score | 0.44 | 0.87 | 0.55 | 0.94 | 1.25 | 1.43 | 1.33 | 1.66 | < .0001 |
Age | 47.83 | 9.02 | 53.71 | 8.5 | 57 | 8.74 | 51.52 | 9.81 | < .0001 |
Length of follow-up (days) | 912.68 | 449.7 | 927.12 | 455.37 | 896.94 | 428.41 | 936.73 | 467.52 | 0.634 |
eGFR (last value) | 109.57 | 12.62 | 76.94 | 8.29 | 47.79 | 8.46 | 19.09 | 6.87 | < .0001 |